Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis

PURPOSE: To assess the safety, efficacy and prognostic impact of clinical factors related to lenvatinib treatment in Child-Pugh class A (CP-A) and class B (CP-B) patients with unresectable hepatocellular carcinoma (u-HCC). METHODS: Patients with u-HCC who were treated with lenvatinib at multiple cent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Gastroenterol
Autors principals: Ogushi, Katsuaki, Chuma, Makoto, Uojima, Haruki, Hidaka, Hisashi, Numata, Kazushi, Kobayashi, Satoshi, Hirose, Shunji, Hattori, Nobuhiro, Fujikawa, Tomoaki, Nakazawa, Takahide, Wada, Naohisa, Iwasaki, Shuitirou, Fukushima, Taito, Sano, Yusuke, Ueno, Makoto, Kawano, Kuniyuki, Tsuruya, Kota, Shomura, Masako, Watanabe, Tsunamasa, Matsunaga, Kotaro, Kunishi, Yosuke, Saigusa, Yusuke, Irie, Kuniyasu, Iwabuchi, Shogo, Kako, Makoto, Morimoto, Manabu, Kagawa, Tatehiro, Tanaka, Katsuaki, Maeda, Shin
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534867/
https://ncbi.nlm.nih.gov/pubmed/33061517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S256691
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars